ClearNote Health to Present Early Detection Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting

SAN DIEGO — May 22, 2026 — ClearNote Health, a company dedicated to improving early detection for some of the deadliest cancers, today announced it will present new multi-cohort validation data for its Avantect® Pancreatic Cancer Test at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago May 29 – June 2. ASCO attendees are invited to meet with ClearNote Health’s scientific and […] The post ClearNote Health to Present Early Detection Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting appeared first on ClearNote Health .